Terms of Collaboration
Strong of its 15 entities, the CALYM Carnot institute develops research partnerships with pharmaceutical companies, biotechs, in vitro diagnostics or imaging companies to promote emergence of new therapies, new tools and technology transfer.
CALYM offers contract research partnerships on preclinical, translational or clinical (multicenter) projects.
To meet major issues in lymphomas study, understanding and treatment strategies, CALYM’s teams offer joint setting-up of projects on national or international calls for projects.
Platforms and Technical Resources
CALYM offers access to its databases, technical platforms, biological collections, preclinical models, technical resources.
Clinical research, OMICS, flux cytometry, imaging… please, see the resources we have available, to conduct our research and collaboration projects: http://www.calym.org/-Technical-facilities-.html
Whether you want to position or reposition a molecule, interpret data to guide a project or design a program, etc., CALYM offers expertise and consulting of internationally renowned lymphoma experts in R&D, clinical and pathology fields.